Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man.
J E Liljenquist, … , W W Lacy, D Rabinowitz
J E Liljenquist, … , W W Lacy, D Rabinowitz
Published February 1, 1977
Citation Information: J Clin Invest. 1977;59(2):369-374. https://doi.org/10.1172/JCI108649.
View: Text | PDF
Research Article

Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man.

  • Text
  • PDF
Abstract

To investigate the role of glucagon in regulating hepatic glucose production in man, selective glucagon deficiency was produced in four normal men by infusing somatostatin (0.9 mg/h) and regular pork insulin (150-muU/kg per min) for 2 h. Exogenous glucose was infused to maintain euglycemia. Arterial plasma glucagon levels fell by greater than 50% whereas plasma insulin levels were maintained in the range of 10-14 muU/ml. In response to these hormonal changes, net splanchnic glucose production (NSGP) fell by 75% and remained suppressed for the duration of the study. In contrast, when somatostatin alone was administered to normal men, resulting in combined insulin and glucagon deficiency (euglycemia again maintained), NSGP fell markedly but only transiently, reaching its nadir at 15 min. Thereafter, NSGP rose progressively, reaching the basal rate at 105 min. These data indicate that the induction of selective glucagon deficiency in man (with basal insulin levels maintained) is associated with a marked and sustained fall in hepatic glucose production. We conclude, therefore, that basal glucagon plays an important role in the maintenance of basal hepatic glucose production in normal man.

Authors

J E Liljenquist, G L Mueller, A D Cherrington, U Keller, J-L Chiasson, J M Perry, W W Lacy, D Rabinowitz

×

Total citations by year

Year: 2024 2020 2019 2017 2015 2014 2013 2012 2011 2010 2008 2007 2006 2005 2004 2003 2002 2001 2000 1998 1997 1996 1995 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 1982 1981 1980 1979 1978 1964 Total
Citations: 1 2 3 1 5 3 2 3 7 5 2 6 1 1 1 1 1 1 1 5 1 1 1 2 2 3 2 3 3 5 1 2 3 3 3 9 3 5 8 1 113
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (113)

Title and authors Publication Year
The impact of glucagon to support postabsorptive glucose flux and glycemia in healthy rats and its attenuation in male Zucker diabetic fatty rats
Estes SK, Shiota C, O\u2019Brien TP, Printz RL, Shiota M
American journal of physiology. Endocrinology and metabolism 2024
Roux-en-Y gastric bypass surgery improves hepatic glucose metabolism and reduces plasma kisspeptin levels in morbidly obese patients with type 2 diabetes
CR Flynn, VL Albaugh, RA Tamboli, JM Gregory, A Bosompem, RM Sidani, JJ Winnick
AJP Gastrointestinal and Liver Physiology 2020
Glucagon and Liver Fat are Downregulated in Response to Very Low-calorie Diet in Patients with Obesity and Type-2 Diabetes
SL Haas, P Löfgren, P Stål, J Hoffstedt
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2020
Growth hormone enhances the recovery of hypoglycemia via ventromedial hypothalamic neurons
IC Furigo, GO Souza, PD Teixeira, D Guadagnini, R Frazão, EO List, JJ Kopchick, PO Prada, J Donato
The FASEB Journal 2019
Metabolic effects of glucagon in humans
MM Adeva-Andany, R Funcasta-Calderón, C Fernández-Fernández, E Castro-Quintela, N Carneiro-Freire
Journal of Clinical & Translational Endocrinology 2019
Higher glucagon-to-insulin ratio is associated with elevated glycated hemoglobin levels in type 2 diabetes patients
M Lee, M Kim, JS Park, S Lee, J You, CW Ahn, KR Kim, S Kang
The Korean Journal of Internal Medicine 2019
Modeling Glucagon Action in Patients With Type 1 Diabetes
A Emami, JE Youssef, R Rabasa-Lhoret, J Pineau, JR Castle, A Haidar
IEEE J BIOMED HEALTH 2017
Glucagon – Early breakthroughs and recent discoveries
B Ahrén
Peptides 2015
The FOXP1, FOXP2 and FOXP4 transcription factors are required for islet alpha cell proliferation and function in mice
JM Spaeth, CS Hunter, L Bonatakis, M Guo, CA French, I Slack, M Hara, SE Fisher, J Ferrer, EE Morrisey, BZ Stanger, R Stein
Diabetologia 2015
Involvement of steatosis-induced glucagon resistance in hyperglucagonaemia
MP Suppli, A Lund, JI Bagger, T Vilsbøll, FK Knop
Medical Hypotheses 2015
Pancreatic α-Cell Dysfunction in Type 2 Diabetes: Old Kids on the Block
JS Moon, KC Won
Diabetes & Metabolism Journal 2015
Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
DA Sandoval, DA D'Alessio
Physiological reviews 2015
Tissue-specific insulin signaling in the regulation of metabolism and aging: Insulin Signaling in Metabolism and Aging
J Zhang, F Liu
IUBMB Life 2014
Comprehensive Physiology
SN Cheuvront, RW Kenefick
Comprehensive Physiology 2014
Pronounced reduction of postprandial glucagon by lixisenatide: a meta-analysis of randomized clinical trials
B Ahrén, JF Gautier, R Berria, W Stager, R Aronson, CJ Bailey
Diabetes Obesity and Metabolism 2014
Hypothalamic glucagon signaling inhibits hepatic glucose production
PI Mighiu, JT Yue, BM Filippi, MA Abraham, M Chari, CK Lam, CS Yang, NR Christian, MJ Charron, TK Lam
Nature Medicine 2013
Glucagon clearance is regulated by nutritional state: evidence from experimental studies in mice
A Zhou, G Pacini, B Ahrén, DZ D’Argenio
Diabetologia 2013
Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover
Robert H. Unger, Alan Cherrington
Journal of Clinical Investigation 2012
Minireview: Glucagon in the Pathogenesis of Hypoglycemia and Hyperglycemia in Diabetes
PE Cryer
Endocrinology 2012
Evidence against a physiologic role for acute changes in CNS insulin action in the rapid regulation of hepatic glucose production
CJ Ramnanan, DS Edgerton, AD Cherrington
Cell Metabolism 2012
Brain Insulin Action Augments Hepatic Glycogen Metabolism without altering Glucose Production or Gluconeogenesis in the Dog
Christopher Ramnanan, Viswanathan Saraswathi, Marta Smith, Patrick Donahue, Ben Farmer, Tiffany Farmer, Doss Neal, Phil Williams, Maggie Lautz, Andrea Mari, Alan Cherrington, Dale Edgerton
Journal of Clinical Investigation 2011
Physiologic action of glucagon on liver glucose metabolism
CJ Ramnanan, DS Edgerton, G Kraft, AD Cherrington
Diabetes, Obesity and Metabolism 2011
The physiological regulation of glucose flux into muscle in vivo
DH Wasserman, L Kang, JE Ayala, PT Fueger, RS Lee-Young
The Journal of experimental biology 2011
The role of dysregulated glucagon secretion in type 2 diabetes
D D'Alessio
Diabetes, Obesity and Metabolism 2011
International Review of Cell and Molecular Biology
A Chavez, M Smith, D Mehta
International Review of Cell and Molecular Biology Volume 290 2011
Actions physiologiques du glucagon
G Kraft, AD Cherrington
Médecine des Maladies Métaboliques 2011
Glucagon as a Critical Factor in the Pathology of Diabetes
DS Edgerton, AD Cherrington
Diabetes 2011
Glucagon deficiency reduces hepatic glucose production and improves glucose tolerance in adult mice
AS Hancock, A Du, J Liu, M Miller, CL May
Molecular Endocrinology 2010
Textbook of Diabetes
PM Jones, SJ Persaud
Textbook of Diabetes 2010
Adjunct therapy for type 1 diabetes mellitus
HE Lebovitz
Nature Reviews Endocrinology 2010
Glucagon Supports Postabsorptive Plasma Glucose Concentrations in Humans With Biologically Optimal Insulin Levels
BA Cooperberg, PE Cryer
Diabetes 2010
The Physiology of Glucagon
GJ Taborsky
Journal of diabetes science and technology 2010
Novartis Foundation Symposia
EJ Campbell
Ciba Foundation Symposium 44 - Research and Medical Practice: Their Interaction 2008
Islet cell function: α and β cells - partners towards normoglycaemia
B Göke
International Journal of Clinical Practice 2008
A Thr94Ala mutation in human liver fatty acid-binding protein contributes to reduced hepatic glycogenolysis and blunted elevation of plasma glucose levels in lipid-exposed subjects
MO Weickert, CV Loeffelholz, M Roden, V Chandramouli, A Brehm, P Nowotny, MA Osterhoff, F Isken, J Spranger, BR Landau, AF Pfeiffer, M Möhlig
American journal of physiology. Endocrinology and metabolism 2007
The Role of α-Cell Dysregulation in Fasting and Postprandial Hyperglycemia in Type 2 Diabetes and Therapeutic Implications
BE Dunning, JE Gerich
Endocrine reviews 2007
Basal insulin, glucagon, and growth hormone replacement
SM Breckenridge, B Raju, AM Arbelaez, BW Patterson, BA Cooperberg, PE Cryer
American journal of physiology. Endocrinology and metabolism 2007
Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies
J Meece
Current Medical Research and Opinion 2007
Glucagon, in Concert With Insulin, Supports the Postabsorptive Plasma Glucose Concentration in Humans
SM Breckenridge, BA Cooperberg, AM Arbelaez, BW Patterson, PE Cryer
Diabetes 2007
Pharmacokinetics and Pharmacodynamics of Vildagliptin??in??Patients?? with Type??2??Diabetes??Mellitus:
YL He, D Serra, Y Wang, J Campestrini, GJ Riviere, C F, JJ Holst, S Schwartz, JC Nielsen, M Ligueros-Saylan
Clinical Pharmacokinetics 2007
Islet Dysfunction: An Underlying Defect in the Pathophysiology of Type 2 Diabetes
R Pratley
Endocrinology & Metabolism Clinics of North America 2006
Maintenance of the postabsorptive plasma glucose concentration: insulin or insulin plus glucagon?
B Raju, PE Cryer
American journal of physiology. Endocrinology and metabolism 2005
Differential effect of saturated and polyunsaturated fatty acids on hepatic glucose metabolism in humans
JN Clore, JS Stillman, J Li, SJ O'Keefe, JR Levy
American journal of physiology. Endocrinology and metabolism 2004
La variabilité glycémique asymptomatique: comment l'évaluer et quelle est son incidence clinique ?
B Guerci
Diabetes & Metabolism 2003
FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis
G Boden, P Cheung, TP Stein, K Kresge, M Mozzoli
American journal of physiology. Endocrinology and metabolism 2002
ENERGY AND SUBSTRATE METABOLISM IN PATIENTS WITH CHRONIC EXTENSIVE GRAFT-VERSUS-HOST DISEASE:
C Zauner, W Rabitsch, B Schneeweiss, M Schiefermeier, HT Greinix, F Keil, K Ratheiser, P Kalhs
Transplantation 2001
Effects of glucocorticoids on hepatic sensitivity to insulin and glucagon in man
M Dirlewanger, PH Schneiter, N Paquot, E Jequier, V Rey, L Tappy
Clinical Nutrition 2000
Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans
KF Petersen, D Laurent, DL Rothman, GW Cline, GI Shulman
Journal of Clinical Investigation 1998
Effects of glucagon on postpranidal carbohydrate metabolism in nondiabetic humans
JW Frank, M Camilleri, GM Thomforde, SF Dinneen, RA Rizza
Metabolism 1998
Hyperglucagonemia and the immediate fate of dietary leucine: A kinetic study in humans
JS Marchini, LM Marks, D Darmaun, VR Young, M Krempf
Metabolism 1998
Indomethacin stimulates glucose production in adults with uncomplicated falciparum malaria
E Dekker, JA Romijn, HV Thien, MT Ackermans, E Endert, PA Kager, LT Thuy, HP Sauerwein
Metabolism 1998
Principles of Perinatal—Neonatal Metabolism
RM Cowett
1998
Theoretical analysis of the mechanisms of chronic hyperinsulinemia
RL Summers, JP Montani, LH Woodward, TG Coleman, JE Hall
Computers in Biology and Medicine 1997
Gliclazide potentiates suppression of hepatic glucose production in non—insulin-dependent diabetic patients
A Riccio, G Lisato, SV de Kreutzenberg, S Marchetto, M Turrin, A Tiengo, SD Prato
Metabolism 1996
Role of glucagon in maintenance of euglycemia in fed and fasted rats
CL Brand, PN Jorgensen, U Knigge, J Warberg, I Svendsen, JS Kristensen, JJ Holst
American journal of physiology. Endocrinology and metabolism 1995
3 Action of insulin on glucose metabolism in vivo
YJ Hannele
Baillière's Clinical Endocrinology and Metabolism 1993
Contribution of glucose/glucose 6-phosphate cycle activity to insulin resistance in Type 2 (non-insulin-dependent) diabetes mellitus
DP Rooney, RD Neely, O Beatty, NP Bell, B Sheridan, AB Atkinson, ER Trimble, PM Bell
Diabetologia 1993
Idiopathic reactive hypoglycemia: a role for glucagon?
F Leonetti, L Morviducci, A Giaccari, P Sbraccia, S Caiola, D Zorretta, O Lostia, G Tamburrano
Journal of Endocrinological Investigation 1992
Glucose appearance rate following protein ingestion in normal subjects
MA Khan, MC Gannon, FQ Nuttall
Journal of the American College of Nutrition 1992
Hepatic fuel metabolism during muscular work: role and regulation
DH Wasserman, AD Cherrington
American journal of physiology. Endocrinology and metabolism 1991
Principles of Perinatal-Neonatal Metabolism
RM Cowett
1991
Diabetic Hyperglycemia: Link to Impaired Glucose Transport in Pancreatic β Cells
RH Unger
Science 1991
Neuroendocrine mechanisms involved in regulation of body weight, food intake and metabolism
AB Steffens, JH Strubbe, B Balkan, AJ Scheurink
Neuroscience & Biobehavioral Reviews 1990
Insulin
P Cuatrecasas, S Jacobs
Insulin 1990
Recent Advances in Carbohydrate Nutrition and Metabolism in Diabetes Mellitus
JW Anderson
Journal of the American College of Nutrition 1989
Alterations in Digestive Function Caused by Pancreatic Disease
JE Doty, AS Fink, JH Meyer
Surgical Clinics of North America 1989
Regulation of Carbohydrate Metabolism and Response to Hypoglycemia
PC Butler, RA Rizza
Endocrinology and metabolism clinics of North America 1989
Effect of DG5128 on epinephrine and glucagon induced glucose output from the isolated perfused rat liver
M Usami, Y Seino, T Taminato, M Seno, G Koh, M Ohno, M Ikeda, H Imura
Life Sciences 1988
Similar effects of pulsatile and constant intravenous insulin delivery
W Kerner, J Brückel, H Zier, P Arias, C Thun, R Moncayo, EF Pfeiffer
Diabetes Research and Clinical Practice 1988
Alterations in carbohydrate metabolism as they apply to reproductive endocrinology
EE Wallach, MP Diamond, AC Wentz, AD Cherrington
Fertility and Sterility 1988
Role of counterregulatory hormones in the regulation of hepatic glucose metabolism
L Saccà
Diabetes / Metabolism Reviews 1987
Insulin, glucagon, and glucose as regulators of hepatic glucose uptake and production in vivo
AD Cherrington, RW Stevenson, KE Steiner, MA Davis, SR Myers, BA Adkins, NN Abumrad, PE Williams
Diabetes / Metabolism Reviews 1987
Hepatic response to insulin in control of glucose kinetics in the neonatal lamb
RM Cowett, D Tenenbaum
Metabolism 1987
Basal glucose homeostasis with and without fixed concentrations of glucagon and insulin
RA Jackson, JB Hamling, BM Sim, PM Blix, JB Jaspan, S Markanday, JD Nabarro
Metabolism 1987
Effect of somatostatin on nonesterified fatty acid levels modifies glucose homeostasis during fasting
GK Hendrick, RT Frizzell, AD Cherrington
American journal of physiology. Endocrinology and metabolism 1987
Interaction between insulin and counterregulatory hormones in control of substrate utilization in health and diabetes during exercise
DH Wasserman, M Vranic
Diabetes / Metabolism Reviews 1986
Mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes
JM Olefsky, TP Ciaraldi, OG Kolterman
The American Journal of Medicine 1985
Pathogenesis of insulin resistance and hyperglycemia in non-insulin-dependent diabetes mellitus
JM Olefsky
The American Journal of Medicine 1985
Effects of glucagon on plasma amino acids
G Boden, I Rezvani, OE Owen
Journal of Clinical Investigation 1984
Role of basal glucagon levels in the regulation of splanchnic glucose output and ketogenesis in insulin-deficient humans
O Björkman, P Felig, J Wahren
Clinical Physiology 1984
Glucose counterregulation during prolonged hypoglycemia in normal humans
GB Bolli, IS Gottesman, PE Cryer, JE Gerich
American journal of physiology. Endocrinology and metabolism 1984
Release of Glucagon in Male Alcoholics with Vagal Neuropathy
ET Tan, DG Lambie, RH Johnson, EA Whiteside
Alcoholism, clinical and experimental research 1983
Glucagon II
PJ Lefebvre
1983
A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 2. Marked attenuation of the metabolic deterioration by somatostatin
AJ Scheen, G Krzentowski, M Castillo, PJ Lefbvre, AS Luyckx
Diabetologia 1983
METABOLIC EVENTS IN INFANTS OF DIABETIC MOTHERS DURING FIRST 24 HOURS AFTER BIRTH I
C Kühl, GE Andersen, J Hertel, L Mølsted-Pedersen
Acta Paediatrica 1982
Transient hepatic response to glucagon in man: role of insulin and hyperglycemia
E Ferrannini, RA DeFronzo, RS Sherwin
American journal of physiology. Endocrinology and metabolism 1982
Cyclic Nucleotides
JW Kebabian, JA Nathanson
1982
Influence of hypoglucagonemia on splanchnic glucose output during leg exercise in man
O Björkman, P Felig, L Hagenfeldt, J Wahren
Clinical Physiology 1981
Hormonal and metabolic control of hepatic carbohydrate metabolism
A Jakob
Molecular Aspects of Medicine 1981
THE METABOLIC EFFECTS OF CHRONIC HYPERGLUCAGONAEMIA
A Nankervis, J Proietto, KW Ng, FP Alford, R Larkins
Clinical Endocrinology 1981
Glucagon-Biochemistry, Physiology and Pathophysiology
H Schenck
Acta Medica Scandinavica 1981
Effect of intermittent physiologic hyperglucagonemia on postprandial plasma glucose levels in normal man
K Mackes, R Rizza, J Gerich
Metabolism 1981
Influence of somatostatin on gastric motility and meal absorption in rhesus monkeys, Macaca mulatta
DJ Koerker, BC Hansen
Metabolism 1981
A familial glucagonoma syndrome
PW Stacpoole, J Jaspan, AG Kasselberg, SA Halter, K Polonsky, FW Gluck, JE Liljenquist, D Rabin
The American Journal of Medicine 1981
Somatostatin and diabetes
JE Gerich
The American Journal of Medicine 1981
Current Topics in Cellular Regulation
G Cahill, T Aoki, R Smith
Current Topics in Cellular Regulation 1981
Glucagon deficiency and hyperaminoacidemia after total pancreatectomy
G Boden, RW Master, I Rezvani, JP Palmer, TE Lobe, OE Owen
Journal of Clinical Investigation 1980
Somatostatin infusion in liver cirrhosis: Glucagon control of glucose homeostasis
AV Greco, L Altomonte, G Ghirlanda, AG Rebuzzi, R Manna, A Bertoli
Diabetologia 1980
Treatment of intractable neonatal hypoglycemia with somatostatin plus glucagon
ZT Bloomgarden, H Sundell, LW Rogers, JA O'Neill, JE Liljenquist
The Journal of Pediatrics 1980
Hormonal mechanisms of recovery from insulin-induced hypoglycemia in man
J Gerich, J Davis, M Lorenzi, R Rizza, N Bohannon, J Karam, S Lewis, R Kaplan, T Schultz, P Cryer
American journal of physiology. Endocrinology and metabolism 1979
Importance of hypoglycemia-induced glucose production during isolated glucagon deficiency
AD Cherrington, JE Liljenquist, GI Shulman, PE Williams, WW Lacy
American journal of physiology. Endocrinology and metabolism 1979
Possible mechanism by which somatostatin-induced glucagon suppression improves glucose tolerance during insulinopaenia in man
JE Liljenquist, ZT Bloomgarden, AD Cherrington, JM Perry, D Rabin
Diabetologia 1979
Contemporary Metabolism
N Freinkel
1979
Studies on alpha-adrenergic activation of hepatic glucose output. Insulin inhibition of alpha-adrenergic and glucagon actions in normal and calcium-depleted hepatocytes
PF Blackmore, F Assimacopoulos-Jeannet, TM Chan, JH Exton
The Journal of biological chemistry 1979
Effect of glucagon on glucose production during insulin deficiency in the dog
AD Cherrington, WW Lacy, JL Chiasson
Journal of Clinical Investigation 1978
Role of glucagon in the pathogenesis of diabetes: The status of the controversy
RH Unger
Metabolism 1978
Glucose metabolism in intact man: The responsiveness of splanchnic and peripheral tissues to insulin
D Rabinowitz, JE Liljenquist
Metabolism 1978
Mesenchymal tumor hypoglycemia
SL Jensen, C Kühl, KB Lauritsen, AJ Moody
The American Journal of Surgery 1978
Regulatory Mechanisms of Carbohydrate Metabolism
SJ Pilkis, TH Claus, JP Riou, AD Cherrington, JL Chiasson, JE Liljenquist, WW Lacy, CR Park
Regulatory Mechanisms of Carbohydrate Metabolism 1978
Pathophysiology of Diabetes Mellitus
R Sherwin, P Felig
Medical Clinics of North America 1978
Somatostatin and Diabetes
RA Rizza, JE Gerich
Medical Clinics of North America 1978
Glucagon and Diabetes
P Raskin, RH Unger
Medical Clinics of North America 1978
Advances in Metabolic Disorders
G Aurbach, JT Potts
Advances in Metabolic Disorders 1964

← Previous 1 2 3 4 5 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts